Campbell & Co Investment Adviser’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-75,581
Closed -$1.12M 1379
2025
Q4
$1.12M Sell
75,581
-32,632
-30% -$461K 0.05% 521
2025
Q3
$1.39M Buy
108,213
+32,070
+42% +$427K 0.11% 296
2025
Q2
$1.16M Buy
76,143
+54,805
+257% +$855K 0.07% 446
2025
Q1
$356K Buy
+21,338
New +$393K 0.03% 798
2024
Q1
Sell
-35,351
Closed -$448K 1343
2023
Q4
$448K Buy
+35,351
New +$446K 0.04% 769
2023
Q3
Sell
-40,192
Closed -$690K 1161
2023
Q2
$690K Buy
+40,192
New +$623K 0.12% 283
2023
Q1
Sell
-16,756
Closed -$224K 1011
2022
Q4
$224K Buy
+16,756
New +$217K 0.05% 656
2022
Q2
Sell
-38,419
Closed -$497K 895
2022
Q1
$497K Sell
38,419
-18,560
-33% -$245K 0.13% 280
2021
Q4
$903K Buy
56,979
+45,843
+412% +$783K 0.31% 72
2021
Q3
$217K Buy
+11,136
New +$221K 0.07% 488
2021
Q2
Sell
-18,931
Closed -$348K 697
2021
Q1
$348K Buy
+18,931
New +$310K 0.21% 182
2015
Q4
Sell
-107,713
Closed -$626K 207
2015
Q3
$626K Buy
+107,713
New +$799K 0.42% 71
2014
Q4
Sell
-203,236
Closed -$1.32M 269
2014
Q3
$1.32M Buy
+203,236
New +$1.57M 0.67% 59

Other funds holding SEM

Campbell & Co Investment Adviser's SEM Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Select Medical (SEM) in Q1 2026, closing a stake of 75,581 shares — an estimated $1.12M sold.

Campbell & Co Investment Adviser first reported a position in SEM in Q3 2014 and held it in 13 quarters. The position peaked at $1.39M in Q3 2025. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

  • Campbell & Co Investment Adviser reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 75,581 Select Medical shares in Q1 2026, an estimated $1.12M.
  • Campbell & Co Investment Adviser first reported a position in Select Medical in Q3 2014 and held it in 13 quarters.
  • Campbell & Co Investment Adviser's Select Medical position peaked at $1.39M in Q3 2025.
  • 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.